Search
Close this search box.
News

Latest Industry Updates

From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.

How ICH E6 (R2) Provides a Win/Win/Win through Risk-Based Study Execution
Participant safety is the clinical trial sector’s top priority – and striving to achieve this laudable...
Read
FDA Extends CRADA With CluePoints To Further Explore A Data-Driven Approach To Quality Oversight In Clinical Trials
KING OF PRUSSIA, PA– FDA and its stakeholders have an interest in assuring the integrity of clinical...
Read
From RBM to RBx: The Keys to Successful Adoption and Implementation
The latest version of the Good Clinical Practice (GCP) quality standard insists that sponsors implement...
Read
ICH E6 (R2) Compliance Webinar Series Available To Watch Now!
“I KNOW ICH E6 (R2) COMPLIANCE  INSISTS ON A RISK-BASED APPROACH TO RUNNING MY TRIALS, BUT HOW AM I GOING...
Read
Detection of Atypical Data in Multicenter Clinical Trials Using Unsupervised Statistical Monitoring
A risk-based approach to clinical research may include a central statistical assessment of data qual...
Read
Parexel Strengthens Risk-Based Monitoring Offering With CluePoints’ New Advanced Statistical Capabilities
Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance...
Read
1 18 19 20 21 22 29
None found. Please check back later!
None found. Please check back later!